Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation
- PMID: 9365894
Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation
Abstract
The nucleotide sequences of the core upstream and precore regions (371 nucleotide length, nt. 1604-1974) of hepatitis B virus (HBV) were analysed sequentially in three subjects who were positive serologically for anti-HBe and had acute clinical exacerbation after immunosuppressive treatment. These patients were asymptomatic HBV carriers before therapy. The results revealed that the mutant with an 8-bp deletion (nt. 1768-1775) located in the basic core promoter region was dominant in the asymptomatic HBV carrier phase in two of three subjects. After exacerbation, however, such mutant clones possessing 8-bp deletion disappeared or decreased in number and were replaced by the clones possessing a precore stop codon mutation G to A (nt. 1896) or by the clones possessing additional contiguous point mutations A to T (nt. 1762) and G to A (nt. 1764) and a new point mutation C to T (nt. 1653). Possible relationships between acute exacerbation of liver function accompanied by mutation and the transition of the dominant clones were discussed.
Similar articles
-
Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.J Med Virol. 2007 Jun;79(6):683-93. doi: 10.1002/jmv.20849. J Med Virol. 2007. PMID: 17457922
-
Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.J Med Virol. 2004 Apr;72(4):551-7. doi: 10.1002/jmv.20044. J Med Virol. 2004. PMID: 14981757
-
Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.J Med Virol. 1999 Apr;57(4):337-44. J Med Virol. 1999. PMID: 10089043
-
[Association of pre-core defective HBV mutant with anti-HBe positive chronic hepatitis].Nihon Rinsho. 1993 Feb;51(2):286-91. Nihon Rinsho. 1993. PMID: 8464147 Review. Japanese.
-
[Precore region mutation in anti-HBe antibody positive asymptomatic healthy carriers].Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):189-94. Nihon Rinsho. 1995. PMID: 12442384 Review. Japanese. No abstract available.
Cited by
-
Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.J Clin Microbiol. 2007 Oct;45(10):3191-7. doi: 10.1128/JCM.00411-07. Epub 2007 Jul 25. J Clin Microbiol. 2007. PMID: 17652471 Free PMC article.
-
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.Support Care Cancer. 2004 Mar;12(3):191-6. doi: 10.1007/s00520-003-0549-2. Support Care Cancer. 2004. PMID: 15074316
-
Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.Hepat Mon. 2013 Apr 1;13(4):e6496. doi: 10.5812/hepatmon.6496. Print 2013 Apr. Hepat Mon. 2013. PMID: 23805156 Free PMC article.
-
Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.J Natl Cancer Inst. 2009 Aug 5;101(15):1066-82. doi: 10.1093/jnci/djp180. Epub 2009 Jul 2. J Natl Cancer Inst. 2009. PMID: 19574418 Free PMC article.
-
Hepatitis B virus genotypes and precore and core mutants in Brazilian patients.J Clin Microbiol. 2004 Jun;42(6):2455-60. doi: 10.1128/JCM.42.6.2455-2460.2004. J Clin Microbiol. 2004. PMID: 15184419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials